B.Riley Resumes Fusion Pharmaceuticals (FUSN) at Buy
Tweet Send to a Friend
(Updated - December 1, 2022 5:38 AM EST)
B.Riley analyst Yuan Zhi resumes coverage on Fusion Pharmaceuticals (NASDAQ: FUSN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
B.Riley analyst Yuan Zhi resumes coverage on Fusion Pharmaceuticals (NASDAQ: FUSN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
